Jul 10, 12:35 PM

Barclays Raises Eli Lilly Price Target to $1,025 for Q2 Earnings Optimism

Barclays analysts expect Eli Lilly ($LLY) to surpass earnings estimates, raising the price target from $913 to $1,025. The company is anticipated to outperform in its upcoming quarterly results on August 8.

#Barclays #Eli Lilly

Written with ChatGPT (GPT-3).

Sources

CNBC@CNBC
2 years ago
Thursday's analyst calls: Spotify gets an upgrade, Costco price target increase https://t.co/ZqsoK2sRl9
TheStreet@TheStreet
2 years ago
Analysts revamp Eli Lilly stock price target ahead of Q2 earnings https://t.co/nyRcEZsmhW
CNBC@CNBC
2 years ago
Here are Wednesday's biggest analyst calls: Nvidia, Apple, Netflix, Meta, Tesla, Eli Lilly, Walmart, Microsoft, Oracle & more https://t.co/1kkCXFWwC6

Additional media

Image #1 for story barclays-raises-eli-lilly-price-target-to-1025-q2-earnings-optimism

Image #2 for story barclays-raises-eli-lilly-price-target-to-1025-q2-earnings-optimism

Image #3 for story barclays-raises-eli-lilly-price-target-to-1025-q2-earnings-optimism

Image #4 for story barclays-raises-eli-lilly-price-target-to-1025-q2-earnings-optimism

Image #5 for story barclays-raises-eli-lilly-price-target-to-1025-q2-earnings-optimism

Barclays Raises Eli Lilly Price Target to $1,025 for Q2 Earnings Optimism

Sources

Additional media

Similar Stories